PEGFOSIMER MANGANESE
UNII AL3SS4ED7K

Substance Identification & Data

This profile provides standardized clinical and technical data for Pegfosimer Manganese, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AL3SS4ED7K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2641234-28-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AL3SS4ED7K
CAS Registry Number
2641234-28-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PEGFOSIMER MANGANESE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C199088
National Cancer Institute reference terminology for clinical and research data.
INN ID
12178
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
specifiedSubstanceG1
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pegfosimer Manganese. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEGFOSIMER MANGANESE

Common Names & Synonyms

PEGFOSIMER MANGANESE [INN]
POLYMER NANOPARTICLES SYNTHESIZED FROM TETRAMETHYL P,P'-(1,7-BIS(TRIETHOXYSILYL)HEPTANE-4,4-DIYL)BISPHOSPHONATE (~52 MOLECULES PER PARTICLE ON AVERAGE) BY (I) HYDROLYSIS OF THE TRIETHOXYSILYL GROUPS AND ~75% OF THE DIMETHYL PHOSPHONATE GROUPS AND CONDENSATION OF THE RESULTING BIS-SILANETRIOL TO A POLYMERIC NETWORK WITH SI-O-SI LINKAGES, (II) COATING OF THE CORE PARTICLES BY HYDROLYSIS OF .ALPHA.-((3,5-BIS(3-(TRIETHOXYSILYL)PROPOXY)PHENYL)METHYL)-.OMEGA.-METHOXYPOLY(OXYETHYLENE) (~18 MOLECULES PER PARTICLE ON AVERAGE) AND CONDENSATION OF THE RESULTING SILANETRIOL GROUPS WITH SURFICIAL SILANOL GROUPS, AND (III) ADDITION OF A MANGANESE(2+) SALT TO FORM HYDRATED POLYMERIC AMMONIUM MANGANESE(2+) SODIUM (? 29:13:65) PHOSPHONATE COMPLEXES

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus